PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS
Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compa...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-03-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/38 |
| _version_ | 1797878957903708160 |
|---|---|
| author | M. V. Protsenko |
| author_facet | M. V. Protsenko |
| author_sort | M. V. Protsenko |
| collection | DOAJ |
| description | Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compare with Kosopt and combination of Azopt and timolol from cost-minimization and budget impact analysis perspective and can be claimed dominant. Futhermore Azarga in comparison with Dorzopt plus is cost-effective drug, because of Azarga incremental cost-utility ratio is lower than willingness-to-pay threshold value for Russia. |
| first_indexed | 2024-04-10T02:40:16Z |
| format | Article |
| id | doaj.art-a2fa8bb3bc4e4fdea9c7fa08009073fe |
| institution | Directory Open Access Journal |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| last_indexed | 2024-04-10T02:40:16Z |
| publishDate | 2015-03-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj.art-a2fa8bb3bc4e4fdea9c7fa08009073fe2023-03-13T07:48:14ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-03-0153273232PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERSM. V. Protsenko0Laboratory of pharmacoeconomic researches of the First Moscow State Medical University named after I.M. Sechenov, MoscowAbstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compare with Kosopt and combination of Azopt and timolol from cost-minimization and budget impact analysis perspective and can be claimed dominant. Futhermore Azarga in comparison with Dorzopt plus is cost-effective drug, because of Azarga incremental cost-utility ratio is lower than willingness-to-pay threshold value for Russia.https://www.pharmacoeconomics.ru/jour/article/view/38primary open-angle glaucomapharmacoeconomic studiescost-utility analysiswillingness-to-pay analysiscost minimization analysisbudget impact analysistimololbrinzolamid |
| spellingShingle | M. V. Protsenko PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS Фармакоэкономика primary open-angle glaucoma pharmacoeconomic studies cost-utility analysis willingness-to-pay analysis cost minimization analysis budget impact analysis timolol brinzolamid |
| title | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS |
| title_full | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS |
| title_fullStr | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS |
| title_full_unstemmed | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS |
| title_short | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS |
| title_sort | pharmacoeconomic study of primary open angle glaucoma treatment with fix combination of carbonic anhydrase inhibitors and betablockers |
| topic | primary open-angle glaucoma pharmacoeconomic studies cost-utility analysis willingness-to-pay analysis cost minimization analysis budget impact analysis timolol brinzolamid |
| url | https://www.pharmacoeconomics.ru/jour/article/view/38 |
| work_keys_str_mv | AT mvprotsenko pharmacoeconomicstudyofprimaryopenangleglaucomatreatmentwithfixcombinationofcarbonicanhydraseinhibitorsandbetablockers |